Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Intrexon Corp (XON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 923,956
  • Shares Outstanding, K 160,409
  • Annual Sales, $ 160,570 K
  • Annual Income, $ -509,340 K
  • 60-Month Beta 2.37
  • Price/Sales 5.44
  • Price/Cash Flow N/A
  • Price/Book 1.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.24
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.30
  • Prior Year -0.17
  • Growth Rate Est. (year over year) -41.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.05 +35.56%
on 03/04/19
8.58 -36.01%
on 02/25/19
-2.78 (-33.62%)
since 02/22/19
3-Month
4.05 +35.56%
on 03/04/19
9.10 -39.67%
on 01/18/19
-1.28 (-18.91%)
since 12/21/18
52-Week
4.05 +35.56%
on 03/04/19
20.16 -72.77%
on 04/13/18
-10.82 (-66.34%)
since 03/22/18

Most Recent Stories

More News
Next Green Wave's Nursery Botticelli(TM) Research & Development Program Begins

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2019) - ("", or the ), is pleased to announce that is has begun the optimization phase of the strategic licensing agreement with to utilize Intrexon's...

NGW.CN : 0.620 (-6.06%)
XON : 5.37 (-6.77%)
NXGWF : 0.4990 (+1.84%)
AquaBounty Technologies, Inc. Announces Closing of Public Offering of Common Stock

AquaBounty Technologies, Inc. (Nasdaq: AQB) ("AquaBounty" or the "Company"), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon...

AQB : 2.28 (+1.33%)
XON : 5.37 (-6.77%)
NHLD : 3.05 (-3.79%)
CORRECTION - AquaBounty Technologies, Inc.

In a release issued earlier today by AquaBounty Technologies, Inc. (Nasdaq: AQB), please note that the headline should be "AquaBounty Technologies, Inc. Announces Pricing of $7.5 Million Public Offering...

AQB : 2.28 (+1.33%)
XON : 5.37 (-6.77%)
NHLD : 3.05 (-3.79%)
AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock

AquaBounty Technologies, Inc. (Nasdaq: AQB) ("AquaBounty" or the "Company"), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon...

AQB : 2.28 (+1.33%)
XON : 5.37 (-6.77%)
NHLD : 3.05 (-3.79%)
AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock

AquaBounty Technologies, Inc. (Nasdaq: AQB) ("AquaBounty" or the "Company"), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon...

AQB : 2.28 (+1.33%)
XON : 5.37 (-6.77%)
AquaBounty Technologies, Inc. - FDA Lifts Import Alert on AquAdvantage Salmon

AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon...

AQB : 2.28 (+1.33%)
XON : 5.37 (-6.77%)
AquaBounty Technologies, Inc. Results for the year ended December 31, 2018

AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon...

AQB : 2.28 (+1.33%)
XON : 5.37 (-6.77%)
Market Trends Toward New Normal in Ritchie Bros. Auctioneers, Empire State Realty Trust, Synergy Resources, IQVIA, Intrexon, and Denbury Resources -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ritchie Bros. Auctioneers...

RBA : 33.35 (-1.39%)
ESRT : 15.79 (-1.13%)
SRCI : 5.09 (-6.78%)
XON : 5.37 (-6.77%)
DNR : 1.90 (-2.56%)
SYRG : 8.13 (+0.87%)
IQV : 141.59 (-1.85%)
Intrexon and Surterra Wellness to Collaborate on Botticelli(TM) Next Generation Plant Propagation for Cannabis Cultivation

Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced a strategic licensing agreement...

XON : 5.37 (-6.77%)
Intrexon Corp Falls 32.62% on Heavy Volume: Watch For Potential Rebound

Intrexon Corp (NYSE:XON) traded in a range yesterday that spanned from a low of $5.37 to a high of $6.69. Yesterday, the shares fell 32.6%, which took the trading range below the 3-day low of $8.02 on...

XON : 5.37 (-6.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade XON with:

Business Summary

Intrexon Corporation is a biotechnology company. It provides synthetic biology services. The Company designs and produces modular DNA control systems and applications for human therapeutics, protein production, industrial products, agricultural biotechnology, and animal sciences. Its technologies include...

See More

Key Turning Points

2nd Resistance Point 6.10
1st Resistance Point 5.93
Last Price 5.37
1st Support Level 5.45
2nd Support Level 5.14

See More

52-Week High 20.16
Fibonacci 61.8% 14.01
Fibonacci 50% 12.10
Fibonacci 38.2% 10.20
Last Price 5.37
52-Week Low 4.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar